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ABSTRACT 
 
 
In primates, complement-coated invading microbes and immune complexes are 
efficiently removed from circulation by binding complement receptor-1 (CR1) on 
erythrocytes, a process known as immune-adherence clearance.  This project examines 
the nature and functionality of complement binding to erythrocytes under normal and 
pathological conditions. The data identifies key factors associated with the complement-
CR1 ligation pathway promoting membrane deformability, helping elucidate a greater 
understanding of this important, unique erythrocyte function. 
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BACKGROUND 
 
 
Erythrocytes: Introduction 
Red blood cells (RBCs) are the most common type of blood cell in vertebrates 
and an essential component to an organism’s survival. In the process known as 
erythropoiesis, as many as two million RBCs per second are produced in the bone 
marrow. With a lifespan of 120 days, RBCs constantly circulate throughout the body, 
keeping all other cells alive through oxygenation and removal of immune particles in 
primates.  
 
Erythrocyte Structure 
Erythrocytes are unique among cell types in that they completely lack organelles, 
including a nucleus. Packed within the cell is the metalloprotein hemoglobin, a dense, 
iron complex that binds molecules for transport such as oxygen and carbon dioxide. 
Spanning roughly 8 micrometers in diameter, RBCs are biconcave, with a slight 
depression in the middle. Given its simple structure and lack of organelles, RBCs have 
been used for decades as a model system in studying cell membranes, and how biological 
and chemical signals within the cell affect cell response (Dao et al., 2003). 
Scattered throughout RBC membranes are several integral and membrane 
spanning proteins that interact with the surrounding tissues and circulating immune 
complexes. The membrane is constructed to allow two types of interactions. The first is 
horizontal interactions between the networks of skeletal proteins located underneath the 
membrane. These connections support the structural integrity of erythrocytes, and play a 
major role in the elasticity and deformability of the membrane. The second plane of 
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structure involves vertical interactions between the lipid skeletal network and the integral 
proteins in the membrane, which are important in stabilizing the lipid bilayer (Corrons, 
2011).  
 
Membrane Deformability 
 A key characteristic of the RBC membrane is its ability to bend and fold onto 
itself. This uniaxial folding affects the size and shape of the cell. The biconcavity of the 
cell contributes to a greater average surface area than average cell volume (135 µm
2
 to 94 
µm
3
, respectively). Thus, there is a considerable excess area allowing for RBCs to 
deform (Chien, 1987). Erythrocyte deformability is extremely important for an effective 
microcirculatory function, given that the diameter of capillaries is 3-4 µm. Blood flow 
and viscosity are influenced significantly by this ability. Membrane deformability is 
possible due to two coupled components surrounding the cytoplasm, the lipid bilayer and 
its underlying scaffolding (Van Dort et al., 2001). The lipid bilayer is composed of a 
variety of lipids including phospholipids, glycolipids, cholesterol, and sphingolipids.  
Embedded within, or transecting, the bilayer are several structural proteins, primarily 
glycophorins and band-3 protein. Underneath the lipid bilayer is a 2D scaffolding system, 
composed of interconnecting skeletal proteins, predominantly spectrin and actin. The 
bilayer and scaffolding are anchored together at several locations by bridging proteins, 
such as ankyrin, in the lipid bilayer, as well as by amphiphilic surfactant molecules. 
These proteins play a dominant role in membrane structure and its mechanical ability to 
bend and deform. 
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The ability of RBCs to fit through capillaries to exchange gases and remove 
immune complexes is heavily dependent on the deformability of the membrane, its ability 
to bend and fold without disrupting its function or causing cell fragmentation. Skeletal 
proteins embedded in the membrane play a crucial role in deformability. The mechanical 
work attributed by the spectrin network has been shown to depend on the 
phosphorylation of β-spectrin, adducin, and protein 4.1R (Manno et al., 1995; Manno et 
al., 2005). 
Decreased erythrocyte deformability can have significant consequences on 
surrounding proteins and tissues. It has been shown that aged cells do not deform as 
efficiently as younger cells (Wen et al., 1998). Diseases such as sepsis and lupus are also 
associated with an increase in membrane rigidity. High shear stress, turbulence, and 
hypothermia are other conditions that can negatively influence overall RBC functionality 
(Kameneva et al., 1999). In particular, oxidative stress caused by free radicals is 
especially detrimental to erythrocyte deformability. These reactive oxygen species (ROS) 
can destroy fatty acids in the membrane and fragment membrane proteins.  
 
Spectrin 
Spectrins are the most abundant RBC membrane skeletal proteins, constituting 
approximately 75% of all membrane associated proteins (Yawata, 2003). They represent 
the major portion of the scaffold network that interacts with the integral proteins of the 
membrane. RBC spectrins are composed of a heterodimer, the α-spectrin and the β-
spectrin subunits which are structurally aligned in an antiparallel arrangement. It has been 
shown through electron microscopy that the entire molecule appears as a twisted,  rod-
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like structure (Yawata, 2003).  Spectrin molecules are tightly coiled in their native state, 
and are able to extend to a more relaxed state when the RBC membrane is stretched. Due 
to this high level of flexibility, spectrins have been classified as one of the major 
determinants of cell shape. 
 β-spectrin in particular has been linked to membrane deformability due to a 
sequence on the polypeptide that contains at least four phosphorylation sites for casein 
kinase 1 (CK1).  It has been shown that the phosphorylation of β-spectrin at these sites is 
directly related to membrane deformability (Manno et al., 1995): the phosphorylated state 
increases deformability. The β-spectrin subunit also contains sites along its sequence that 
bind to other structural proteins, such as actin, protein 4.1, and ankyrin. 
 The formation of the mesh structure is predominately determined by the self-
association of spectrin heterodimers. The head-head and side-side interactions of the 
spectrins allow the formation of higher level oligomers, thus creating the cytoskeletal 
meshwork. In addition, the linkage of spectrins to other RBC membrane proteins is 
essential for changes in deformability. 
 
Erythrocyte Immune Adherence Clearance 
The most well-known function of the RBC is gas exchange, delivering oxygen to 
the tissues, and taking carbon dioxide away.  In primates, however, this is not their sole 
function.  RBCs in primates are also responsible for mediating the process known as 
immune-adherence clearance, an extremely important, yet relatively less known task of 
removing both microbes and immune particles from the body (Figure-1).  To avoid the 
buildup of antibody-bound infectious agents and inflammatory particles, primates employ 
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erythrocytes to remove these complexes from the intravascular space. These particles are 
coated with complement fragments and bind to a receptor on RBCs known as 
complement receptor 1 (CR1, CD35) (Nielsen, 
et al., 2002). This is a very important function, 
as it prevents deposition of circulating immune 
complexes inside fragile organs such as the 
kidney, as well as indirectly activating 
circulating leukocytes. By recognizing these 
complement-tagged particles through CR1, 
RBCs immobilize and transfer them to nearby 
macrophages for phagocytosis, or to the liver and 
spleen where complement is removed without damaging the RBC.  
 
The Complement System 
The complement system is part of the innate immune system, and an additional 
tool used to destroy pathogens. This collection of small proteins combines to opsonize 
(tag) pathogens and immune complexes to facilitate their removal from the body. The 
process also induces chemotaxis, bringing in macrophages to ingest the complexes by 
phagocytosis.  The final component of complement-mediated lysis is the formation of a 
membrane attack complex (MAC), which consists of several complement fragments 
(Figure-2). The arrangement of these fragments induces a rush of extracellular fluids into 
the cell, compromising the integrity of the RBC membrane, and eventually lysing the 
cell. However, mammalian cells, unlike simple bacteria, possess a range of complement-
Figure-1: Diagram of Human 
Immune-Adherence Clearance 
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regulatory factors that control the pathway before a MAC is formed (Hourcade et al., 
1989). 
      
Figure-2: Formation of the MAC Complex. (Kaiser, 2011) 
 
Complement Pathway 
The complement system can be activated by three different pathways:  the 
classical, alternative, and lectin pathways (Figure-3). All three converge with the 
formation of the C5 convertases, which leads to the initiation of the MAC (Nielsen et al., 
2002).  Erythrocytes engage with complement fragments through the classical and 
alternative pathway, where regulatory 
complement factors CR1, DAF, and 
MCP bind to newly formed C3-
convertase, a precursor to C5 
convertase. This binding disrupts the 
continuation of the complement 
pathway, halting the formation of the 
MAC complex. 
 
Figure-3: Diagram of the 
Complement Pathways (Mihaly, 
2011) 
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Complement Activation 
The complement fragments specifically related to erythrocyte binding are the C3 
and C4 fragments, both of which are found in their precursor form circulating in the 
plasma. Both fulfill analogous functions in the formation of the C3 convertase of the 
classical and alternative pathways (Isenman, 1983). In the classical pathway, C4 is 
converted to its active form when it is cleaved by C1s, a molecule generated from the 
interaction of C1 and an immune complex. The resulting major fragment, C4b, is 
involved in the assembly of the C3 convertase (Muller-Eberhard et al., 1966). 
Additionally, C4b becomes a ligand for the type I complement receptor 1 (CR1) present 
on blood cells (Bianco & Nussenzweig, 1977). In a similar fashion, C3 is cleaved by a C3 
convertase enzyme, producing a major fragment C3b, which can interact with other 
proteins, as well as ligating to the CR1 receptor (Reid & Porter, 1981). 
 
Complement Receptor 1 
RBCs circulate throughout the body nearly half a million times in their lifespan, 
constantly binding with molecules to ensure a homeostatic environment. The binding is 
mediated through extracellular peripheral and membrane-spanning proteins, especially 
complement receptors.  Complement receptor 1 (CR1, CD35) is a polymorphic 
glycoprotein found on most human blood cells, notably erythrocytes, leukocytes, and 
dendritic cells. It is the central component for binding activated fragments of the 
complement pathway (Fearon, 1980). This Type 1 transmembrane protein mediates the 
binding of complement-activated immune complexes to RBCs (Nelson, 1953). It is 
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through this receptor that erythrocytes are able to bind and remove immune particles 
from the blood, so it is referred to as the immune adherence receptor. 
Complement receptor 1 is anchored to the lipid membrane with an extracellular 
N-terminal portion composed of 30 repeats of 59-72 amino acids (Klickstein et al., 1987). 
These repeats fold into long homologous modules (LHR), a conserved feature among the 
family of complement activation regulators (RCA) (Liszewsi & Atkinson, 1998). There is 
significant diversity among these modules apart from 4 Cys residues and a conserved Trp 
(Smith et al., 2002).  It is through these structural motifs that CR1 can bind to the 
activated on C3b and C4b fragments via a thioester bond. 
It has previously been shown that CR1 is dispersed across the plasma membrane 
of circulating human RBCs, and clusters together following ligation by immune particles 
through interactions with Fas-associated phosphatase-1 (FAP-1) (Ghiran et al., 2008). 
The receptor undergoes this lateral movement largely because of the spectrin network 
beneath the membrane (Brown, 2003). It is also important to note that the mean number 
of CR1 receptors per erythrocyte is genetically determined, with RBCs expressing about 
100 CR1/cell for low CR1 expressers, to 500/cell on intermediate CR1 expressers, and 
1,000/cell on high CR1 expressers (Wilson et al., 1982). A decrease in receptor number 
due to disease can affect the transport of these immune particles by erythrocytes. In 
addition, a low number of CR1 has been linked to a reduced immune complex binding 
efficiency (Madi et al., 1990). 
The activation of CR1 leads to the deposition of C3b and C4b fragments onto a 
target.  These complexes are reversibly bound and are transported by CR1 on 
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erythrocytes from the peripheral blood vessels to the liver. CR1 is also expressed on other 
blood cells with various functions. 
 
Glycophorin A 
In addition to CR1, the predominant receptor responsible for complement ligation, 
erythrocytes have another membrane protein that has been shown to bind complement. 
Glycophorin A (GPA) is a Type I transmembrane protein and a major sialoglycoprotein 
found on the membrane of erythrocytes (Winzler, 1969). It is characterized as such due to 
the glycosylated regions found on the extracellular NH2-end of the protein. GPA is the 
most abundant protein of the glycophorin family, present at 5-9 x 10
5
 copies per cell, 
amounting to approximately 1.5% of the total RBC membrane protein (Chasis and 
Mohandas, 1992). It has been linked with complement ligation on RBCs in pathological 
cases where there is an excessive of C3b/C4b fragments in the intravascular space. This 
is mediated through the hydroxyl residues on the sialic acid expressed on GPA, which 
bind covalently to the free thioester groups on the complement fragments. The pathway 
triggered from this ligation is not fully understood. 
 
Complement Pathology 
Activated complement has a beneficial impact on the body’s ability to identify 
and clear microbes. This mechanism is employed by the innate immune system, and has 
an additional effect in promoting erythrocyte deformability, a vital characteristic of 
RBCs.  However, excess circulating complement has a negative impact on RBCs.  
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Sepsis (Acute Complement Conditions) 
Systemic inflammatory response syndrome (SIRS), also known as sepsis, is an 
acute illness resulting from a severe host response towards infectious diseases, 
predominantly bacteria. SIRS is viewed as a complication to an infection when chemicals 
released throughout the body trigger a chain of events mediated by inflammatory 
particles that disrupt the function of multiple organ systems. These particles are naturally 
found in the bloodstream, and as complications arise, blood flow and blood pressure 
drop, resulting in organ failure. Sepsis can have a range of severity, but is most lethal in 
the elderly, or patients with a weakened immune system. Despite the advances of modern 
medicine and pharmaceutical industries to curb these infections, the fight against sepsis 
and indirect bacterial infections appears to be an endless one, due to microorganisms’ 
ability to evolve and modify their resistance to these drugs.  Although complement 
deposition is a key player in the immune system’s arsenal against infectious diseases, it 
mediates the worsening conditions and complications in septic patients. 
 
Systemic Lupus Erythematosus (Chronic Complement Conditions) 
Systemic Lupus Erythematosus (SLE) is a long-term, auto-immune disease that is 
difficult to diagnose due to its wide range of symptoms. It can affect many tissues and 
organs of the body, causing inflammation and pain. Increased levels of plasma 
complement have been identified in connection with many pathological disorders, 
especially in patients with SLE (Walport, 2002). It is, however, difficult to use these 
levels in determining the activity of a disease in a clinical setting, because normal 
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complement levels vary between individuals, and the degree of complement in serum 
may not accurately reflect its activity in tissues. 
 
Ghiran Lab’s Main Interests 
The long term interest of the Ghiran lab is to investigate the interactions between 
complement fragments and peripheral circulatory erythrocytes during normal and 
pathological conditions. The specific focus is on two signaling pathways triggered by 
different receptors, the major recipients for complement fragments on RBCs. The lab’s 
approach is driven by the hypothesis that under inflammatory conditions the complement 
activated CR1 and GPA signaling pathways have opposing effects on mediating the 
RBC’s responsibility of maintaining a homeostatic intravascular environment: ligation of 
CR1 promotes a non-inflammatory response, while GPA ligation signals a 
proinflammatory shift.  The location of complement deposition can have a critical impact 
on the overall RBC via changes in membrane deformability, widely considered one of the 
most important factors controlling microcirculation (Vaya et al., 2002; Koksal et. al., 
2002). The impact of these experiments can contribute to ways to prevent and regulate a 
wide range of pathologies, hereditary and acquired. In particular, sepsis alone in the 
United States is responsible for over 210,000 deaths each year, with associated costs 
estimated at over $16.7 billion (Angus et al., 2001). 
 
Innovative Methods 
The following methods were developed by the Ghiran Lab to quantify critical 
RBC functions affected in pathological settings: 
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- RBC membrane flickering is quantified using time-lapse, positive-low phase 
contrast microscopy. Membrane flickering is a unique marker for RBC functions 
that correlates with membrane deformability and oxygen transport across 
membranes. This is a unique technique we developed to monitor high resolution 
RBC functions (Costa et al., 2008). 
 
- Unique, 2-D microfluidic channels have been specifically developed to study 
RBC membrane deformability in vitro. These devices allow for precise 
visualization of RBC deformability in order to observe the subtle differences in 
physiological and pathological settings faster than any other existing methods. 
 
- Using luminometric methods to quantify the levels of ATP release by RBCs under 
various conditions. ATP, acting on its cognate (purinergic) receptors, is a 
significant pro-inflammatory mediator; therefore its extracellular presence is a 
key indicator on RBC function. 
 
Specific Aims of the Ghiran Lab 
A: Define the functional consequences of complement engagement with RBC  
CR1 and GPA receptors. 
Our lab has shown that, under normal conditions, complement fragments 
deposited on CR1 are transferred more efficiently from RBCs in the microvasculature to 
macrophages in the liver and spleen when compared to free-floating particles (Nelson, 
1953; Pilsczek et al., 2005). It has also been determined that CR1 plays an important role 
in the immune-adherence clearance of bacteria (Li et al., 2010). In pathological settings, 
previous reports from other labs have elucidated that the nascent complement fragments 
excessively generated do not bind to CR1, but rather engage covalently and irreversibly 
to GPA via sialic acid (Parker et al., 1984). We have shown that this complement-GPA 
binding results in a decrease in RBC membrane deformability (Karnchanaphanurach et 
al., 2009), providing the first mechanistic explanation for the alterations in RBC 
microcirculatory flow in pathologies associated with excessive complement activation: 
the RBCs are too stiff to efficiently move. This loss of RBC membrane deformability has 
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functional consequences, decreasing the diffusion of soluble molecules inside RBCs as 
well as oxygen across the membrane (Sakr et al., 2004; De Backer, 2006). 
ATP is a major inflammatory marker actively released by RBCs (Wan et al., 
2008; Sprague et al., 2009). Preliminary data has shown that complement-GPA binding 
significantly increases the overall production and release of ATP from RBCs, with no 
sign of cell lysis. This is a critical concept, as this increase in ATP production would 
constantly activate purinergic receptors on higher order immune complexes such as 
neutrophils, platelets, and endothelial cells (Junger, 2008; Gachet, 2006; Ferrero, 2009), 
promoting a proinflammatory environment. This study identifies a significant, 
unregulated source of ATP that could explain the purinergic overload described in septic 
patients. 
 
B: Delineate the two signal transduction pathways triggered by the  
engagement of complement on RBCs. 
Our hypothesis postulates that complement deposition on RBCs triggers alternate 
pathways depending on the receptor ligated, with one promoting membrane deformability 
and the other impairing it. Thus this second aim investigates the mechanisms contributing 
to the alterations in RBC membrane deformability. 
We have shown that both CR1 and GPA promote a Ca
++
 influx. We hypothesized 
that a stretch-activated cation channel was responsible for the CR1-mediated Ca
++
 influx, 
with a member of the TRPC (transient receptor potential cation channel) family 
potentially linked to this pathway. We have also shown that GPA ligation, not CR1, 
enhances tyrosine phosphorylation of band 3, fully supporting other studies correlating 
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increased band 3 phosphorylation with decreased membrane deformability (Condon et 
al., 2007; Saldanha et al., 2007). Further studies on β-spectrin phosphorylation due to 
CR1/GPA-complement engagement yielded opposite results, where ligated CR1 
promoted an increase in phosphorylation, and GPA stimulated a decrease in 
phosphorylation. The phosphorylation status of skeletal proteins adducin, and protein 4.1 
is dependent on protein kinases A (PKA) and C (PKC) (Matsuoka et al., 1996; Manno et 
al., 2005), while β-spectrin is dependent on casein kinases I (CKI) and II (CKII) (Manno 
et al., 1995). We therefore postulated that these kinases are key players in the 
complement signaling pathways. 
In order to determine the correct sequence of events, our lab intends to determine 
the nature of the Ca
++
 influx, and identify the stretch activating cation channel 
responsible, using Western blotting techniques and flow cytometry readouts. The 
involvement of specific kinases will further be tested using specific inhibitors and 
measuring the phosphorylation levels of skeletal proteins, using similar methodologies. 
Our lab is also interested in defining the purinergic signaling events that occur as 
part of GPA-mediated loss of RBC function. It is postulated that converging signaling 
pathways from GPA ligation and autocrine purinergic receptors promote loss of RBC 
membrane deformability. ATP release, regardless of the stimulus, is dependent critically 
on the signaling cascade that includes adenylyl cyclase, PKA, pannexin-1 and P2X/P2Y 
receptors. Additionally, the involvement of CFTR (cystic fibrosis transmembrane 
conductance receptor) in this cascade is not fully understood. The role of each part of the 
cascade will be addressed through inhibitors and agonists for the enzymes responsible for 
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ATP release and the P2 receptors responsible for the autocrine purinergic signaling in 
RBCs, and measured by luminometric methods. 
 
C: In vivo assessments of complement-altered RBCs in septic and lupus  
patients 
The previous two lab aims are designed for in vitro studies on the functional 
consequences of CR1 and GPA ligation with complement. It is necessary to also measure 
these loss of function effects in vivo. Due to critical differences between the rodent and 
human immune clearance system, it is impossible to use mice for these studies. Rodent 
immune adherence is based on the platelet, they lack CR1 as an independent molecule, 
and their GPA is significantly different from that of humans. Thus, we will use RBCs 
drawn from septic (acute conditions) and lupus (chronic conditions) patients, two 
pathologies with known severe complement activation. These will be compared to RBCs 
under physiological conditions. 
 
Physiological Relevance 
The study of these objectives in our lab will have a significant impact on the 
current understanding of the mechanisms responsible for the mortality and morbidity 
surrounding all diseases associated with excessive complement activation. By 
investigating the RBC interactions through CR1 in a normal setting, as well as the GPA 
and purinergic mechanisms, this research may lead to the development of novel 
therapeutic approaches to interrupt the signaling cascades responsible for the loss of RBC 
function and proinflammatory reprogramming.  
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PROJECT PURPOSE 
 
 The purpose of this MQP project was to pursue a portion of our lab’s objectives to 
help determine the functional effects of complement engagement with RBC receptors. 
This project will help confirm the main hypothesis of our lab that under inflammatory 
conditions, complement-activated CR1 and GPA signaling pathways have opposing 
effects on mediating the RBC’s responsibility of maintaining a homeostatic intravascular 
environment: ligation of CR1 promotes a non-inflammatory response, while GPA 
ligation signals a proinflammatory shift.   
 CR1-mediated Ca
++
 influx will be investigated, as will the stretch-activated cation 
channel responsible this Ca
++
 influx, using Western blotting and flow cytometry 
techniques. The functional effects of extracellular ATP released by RBCs upon CR1 
ligation will be demonstrated through microscopy and flow cytometry. Additional 
experiments regarding membrane deformability of RBCs will be conducted using unique 
2D microfluidic devices. Complement-opsonized beads will be prepared to mimic 
fragments circulating the intravascular system, instead of using antibody-mediated 
binding.  
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METHODS 
 
Antibodies and Reagents 
The following antibodies were used during this project: anti-CR1 monoclonal Ab 
YZ-1, non-immune IgG1 (BD Biosciences, San Jose, CA); anti-TRPC1 rabbit polyclonal 
(Santa Cruz, Santa Cruz, CA); T1E3 inhibitor (gift of Yao Xiaoqiang, University of Hong 
Kong). Secondary Abs included: Alexa Fluor 488 goat anti-mouse IgG, Alexa Fluor 488 
goat anti-rabbit IgG (Life Technologies, Grand Island, NY); horseradish peroxidase 
(HRP)-goat anti-mouse IgG, HRP-donkey anti-goat IgG, and HRP-donkey anti-rabbit 
IgG (Jackson ImmunoResearch, West Grove, PA). Reagents were obtained as follows: 
Hank’s Balanced Salt Solution with Ca++ and Mg++ (HBSS++), Fluo-4-AM, 0.2 μm non-
fluorescent sulfate latex microspheres (microbeads) (Life Technologies), IgG-free BSA 
(Jackson ImmunoResearch), citrate (4% w/v), dextran T500, cold water fish gelatin, 
glycine (Sigma-Aldrich, St. Louis, MO), GsMTx-4 (Peptide Institute, Osaka, Japan), 
4,5,6,7-tetrabromobenzotriazole (TBB) (R & D Systems, Minneapolis, MN), apyrase 
(adenosine diphosphatase) (Tocris, Bristol, United Kingdom). 
 
Fresh RBC Isolation 
Blood was obtained from healthy adult volunteers in accordance with the 
guidelines of the Institutional Review Board (IRB) of Beth Israel Deaconess Medical 
Center, and after informed consent was obtained, in accordance with the Declaration of 
Helsinki. RBCs were obtained either by fingerprick (10-50 μL) or by venipuncture (40 
mL) if more was needed. Blood acquired through venipuncture was centrifuged at 300 x 
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g, and plasma, buffy coat and top layer of RBCs were aspirated.  RBCs were washed at 
least 3 times in HBSS
++
 containing 0.05% IgG-free BSA. 
 
Preparation of Complement-Opsonized Microbeads for Microscopy 
Latex beads (0.2 μm) (Life Technologies) were sonicated for separation, and then 
incubated for 3 minutes with BSA Fluo 647 (stored at -20°C) in HBSS
++
.  Beads were 
washed 5 times to remove excess BSA, and then incubated with anti-BSA IgG for 10 
minutes. Beads were washed again, and then incubated with human serum for 8 minutes 
to prevent the degradation of newly formed C3b/C4b fragments. Beads were spun down 
and washed 3 times and resuspended in 100 μL HBSS++, and then sonicated. The quality 
of the beads (lack of aggregation) was checked by fluorescence microscopy using a 647 
nm filter cube. 
 
Analysis of RBC Calcium Influx 
RBCs were preloaded with Fluo-4 AM for 15 minutes at room temperature, 
washed, and resuspended in HBSS
++
. Due to the ATP-depleting effect of the 
acetoxymethyl group, all experiments were performed within one hour from Fluo-4 AM 
loading. Fluorescence levels of RBCs were acquired for 20 seconds using a LSRII flow 
cytometer (Becton Dickinson, Mountain View, CA) to establish a baseline for 
intracellular RBC Ca
++
 concentration. Non-fluorescent control or complement-opsonized 
beads were then added to the RBCs, vortexed briefly, and RBC fluorescence intensity 
was recorded for 2 minutes. Data was exported as FSC 3.0 files and analyzed using the 
kinetic module of FlowJo 9.0.1 (Treestar, Inc., Ashland, OR). 
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Western Blotting Analysis 
RBCs (2 μL packed cells) were washed and lysed in 100 μL of 1 x NUPAGE 
LDS Sample Buffer (Life Technologies) and kept at 37°C. Samples were run on 10% 
Tris gels (Life Technologies), transferred to nitrocellulose paper (Pierce, Rockford, IL), 
and blocked with blotting-grade blocker (Bio-Rad, Hercules, CA). Membranes were then 
incubated with proper primary and secondary antibodies, as indicated in the figure 
legends and according to the manufacturer’s instructions. Blots were developed using the 
LAS 4000 imaging system (FujiFilm, Edison, NJ). 
 
Flow Cytometry Analysis 
Isolated RBCs were incubated for 15-30 minutes with appropriate Abs or 
inhibitors as noted in the figure legends in 0.5% BSA in HBSS
++
 buffer at 4°C. The cells 
were then washed and incubated with Alexa Fluor 488-labeled secondary Ab specific for 
each primary Ab at a dilution following the manufacturer’s instructions. For each 
experiment, at least 10,000 events were recorded using either a FACScan or LRSII flow 
cytometer (Becton Dickinson), and analyzed using either CellQuest Pro version 4.0.1 
(BD Biosciences) or FlowJo 9.0.1 software (Treestar, Inc., Ashland, OR). 
 
RBC Membrane Deformability Assay Using 2D Microfluidic Devices 
To test the efficiency of RBC membrane deformability, 2D filters were developed 
comprising an array of posts with 5x5 μm channel openings using polydimethylsiloxane 
(PDMS). The design of this experimental setup has been previously described in detail 
(Shevkoplyas et al., 2006). In order for the sample to flow through the 2D device, the 
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outlet was connected to a waste reservoir (60 mL syringe) with a 60 cm long piece of PE-
60 tubing filled with HBSS
++
.  The differences in the level of liquid in the reservoir of the 
2D filter device and the level of liquid in the waste reservoir provided the driving 
pressure pushing the samples through the channels. Zero pressure difference 
corresponded to the absence of movement of RBCs in the device.  
Control and CR1 ligated RBCs were loaded into the inlet reservoir and ‘pushed’ 
towards the channels by moving the waste reservoir tubing to a fixed point below the 
zero pressure, driving RBCs towards the outlet. The passage of RBCs through the 2D 
filter was recorded using a 40 x 0.75 Ph2 Plan Fluorite objective on a TE300 Nikon 
inverted microsope, using a Retiga Exi camera (QImaging, Canada) controlled by iVision 
4.01 (BioVision, Exon, PA) at a rate of 10 frames/s. The images were analyzed frame by 
frame to measure the time from initial contact with the channel to egress. Differences in 
passage time between the control and CR1-ligated RBCs were compared using the Mann-
Whitney test, with a p-value of 0.05 or less considered statistically significant. 
 
Determining the Role of ATP in Complement Promoted CR1 Clustering 
Alexa Fluor 647 fluorescently-labeled complement-opsonized microbeads were 
prepared as previously described. RBCs were incubated with microbeads for 20 minutes 
in the absence or presence of apyrase. RBCs were then washed and fixed in a 0.05% 
acrolein solution for 5 minutes, and then blocked in a solution containing 0.2% cold 
water fish gelatin, 5% human serum and 0.2 M glycine for 60 minutes. RBCs were then 
incubated with 1 μg/mL of directly-labeled Alexa Fluor 488 anti-CR1 (YZ1) mAb for 15 
minutes. Cells were washed and imaged using a QImaging Rolera EM-C
2
 fitted on an 
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Olympus BX62 microscope controlled by Slidebook 5.0 (Intelligent Imaging 
Innovations, Denver, CO). 
 
Statistical Analysis 
The statistical analysis tests were performed using Prism Version 4.0 (GraphPad 
Software). 
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RESULTS 
 
 
 RBCs are classically described as passive carriers of immune complexes from the 
intravascular environment to resident macrophages in the liver and spleen. The focus of 
this project was to investigate the functional consequences that occur following the 
engagement of RBC complement receptor-1 (CR1) by circulating immune complexes 
during the immune-adherence clearance process. The results show that the ligation of 
RBC CR1 increases membrane deformability, triggers a significant Ca
++
 influx, and 
promotes ATP release that is critical for CR1 clustering and binding efficiency. The most 
important results leading to these conclusions are presented below. 
 
Ligation of RBC CR1 by Complement Induces a Ca
++
 Influx 
Our lab previously reported that RBC CR1 ligation by complement-opsonized 
particles shifts the receptor into large clusters (Ghiran et al., 2008).  We postulated that 
the ligation of RBC CR1 also triggers an influx of Ca
++
 into RBCs. Importantly, the 
expression pattern of CR1 on RBCs is genetically determined, with low donors 
expressing 100 copies of CR1/cell, intermediate donors expressing 500 copies of 
CR1/cell, and high donors expressing 1000 copies of CR1/cell. Therefore, we next asked 
whether the different levels of CR1 expression are associated with the magnitude of CR1-
mediated Ca
++
 influx.  
RBCs isolated from donors with known high or low CR1 levels were loaded with 
Fluo-4 in the presence of HBSS
++
.  RBCs were incubated with non-fluorescent control or 
complement-opsonized beads to mimic the physiological CR1 ligands. The results  
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(Figure-4) show that 
ligation of RBC CR1 with 
complement-opsonized 
beads promoted a sustained 
Ca
++
 influx, with RBCs 
from high CR1 donors 
displaying a more 
pronounced influx (15 nM 
120 nM) than low CR1 donors (15 nM 60 nM) (Figure 4A).  In addition, the RBCs from 
high CR1 donors (1000 copies/cell) bound to fluorescently-labeled complement-
opsonized beads at a greater efficiency than RBCs from low CR1 donors (100 
copies/cell) (Mean Fluorescence Intensity of 440 to 110) (Figure 4B).  Taken together, 
these results show that CR1 ligation triggers a Ca
++
 influx, which is dependent on the 
genetically determined levels of CR1.  It is possible that immune-complexes and 
complement-opsonized particles could augment the Ca
++
 influx simply by the shear stress 
experienced by circulating RBCs, so the next step was to search for an RBC Ca
++
 channel 
that is also a mechanoreceptor. 
 
TRPC1 is Involved in the Ca
++
 Influx Induced by CR1 Ligation 
Transient Receptor Potential Channels (TRPC) are a group of stretch-activated 
ion channels located on the plasma membrane of numerous human cell types. They are 
typically triggered through mechanical deformations or receptor mediated ligation 
(Johnson, 1994). To investigate the involvement of a stretch-activated cation channel 
(SAC) in CR1-mediated Ca
++
 influx, we used GsMTx-4, a peptide isolated from tarantula 
Figure 4: Ligation of RBC CR1 promotes Ca
++
 influx that depends on the 
genetically determined CR1 levels. A) Ligation of CR1 by complement-opsonized 
particles promotes RBC Ca
++
 influx. Intra-RBC  Ca
++
 concentration of Fluo-4 loaded 
RBCs from known high and low CR1 expressing donors was measured by flow 
cytometry for 20 seconds before RBC CR1 was ligated by control or complement-
opsonized beads. B) Functional characterization of RBC CR1 using complement-
opsonized beads. RBCs from known low and high CR1 expressing donors were 
incubated with fluorescently-labeled complement-opsonized beads for 30 minutes, 
washed, and analyzed by flow cytometry. 
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venom that acts as a non-specific peptide blocker of cationic SAC. Our data (Figure 5A) 
shows that pre-incubation of RBCs with 1 and 5 μM concentrations of GsMTx-4 
progressively inhibited CR1-mediated Ca
++
 influx, measured by flow cytometry. 
Recently, TRPC1 was shown to promote Ca
++
 influx following stretch activation (Maroto 
et al., 2005). First, we investigated its presence in RBCs by using immunofluorescence 
microscopy (data not shown), and immunoblotting methods (Figure 5B). RBC lysates 
were run on a 10% Tris HCl gel, transferred onto nitrocellulose paper, and probed with 
rabbit anti-TRPC1 mAb. The 
developed blot shows that the 
antibody detected a protein 
running at a MW around 85 
kDa (right lane), corresponding 
with the MW of TRPC1 
identified in a testes tissue 
lysate used as a positive control 
(middle lane).  
These results (Figure 4, 
5A, and 5B) demonstrate that a 
SAC was important for CR1-
mediated Ca
++
 influx, and TRPC1 was identified as a cation channel on RBC membranes. 
Thus, the next step was to identify TRPC1’s functional involvement in the CR1-mediated 
Ca
++
 influx. In order to do this, a rabbit anti-serum (T1E3) raised against the extracellular 
portion of TRPC1 was identified as a successful inhibitor of TRPC1 and used for this 
Figure 5: RBCs express functional TRPC1, which mediates Ca
++
 influx from CR1 
ligation. A) RBC CR1 ligation promotes a SAC-dependent Ca
++
 influx. Fluo-4 loaded 
RBCs were incubated with buffer, 1, or 5 μM GsMTX-4 for 30 minutes and then 
analyzed by flow cytometry for CR1-mediated Ca
++
 influx. B) Immunoblotting 
detection of TRPC1 in RBCs. Testes tissue lysate (positive control) and RBC lysate 
were separated by gel electrophoresis using TRIS-HCl gels, transferred onto 
nitrocellulose paper, and probed rabbit anti-TRPC1 Ab. TRPC1 is seen as a band 
around 85 kDa (arrows) in both positive control and RBC lysate. C) CR1 ligation 
triggers a Ca
++
 influx dependent on TRPC1. Fluo-4 loaded RBCs were pre-incubated 
with control serum or T1E3 (TRPC1 inhibitor) for 20 minutes, washed, and analyzed 
by flow cytometry for CR1-mediated Ca
++
 influx. 
 29 
experiment. Following methods used previously in Figure 5A, a time dependent assay 
found that T1E3 successfully prevented CR1-mediated Ca
++
 influx (Figure 5C). It is 
important to note that because the inhibitor came from rabbit serum, RBCs were washed 
3 times before CR1 ligation to prevent Ca
++
 influx through a newly formed C5b-C9 
complex (MAC), an ungated ion channel. Taken together, these results strongly suggest 
that TRPC1 is implicated in CR1-mediated Ca
++
 influx. 
 
CR1 Ligation Increases RBC Membrane Deformability 
The immune-adherence clearance process occurs in capillaries in the liver and 
spleen where RBCs (7-8 μm diameter) are forced to deform through 3-4 μm capillaries 
and through 2-3 μm slits of the wall of the reticulo-endothelial sinusoids to reach resident 
macrophages. Therefore, we hypothesized that CR1 ligation would increase the RBC 
membrane deformability. In addition, we questioned whether the levels of CR1 
expression on RBCs correlate with the magnitude of RBC membrane deformability, as 
mediated by CR1 ligation. This question was addressed using a microfluidic filtration 
device consisting of an array of 320 2D microchannels with a diameter of 4.5 μm and a 
length of 25 μm. The transit time for RBCs through the narrow channel should inversely 
correlate with the magnitude of deformability. RBCs from known high and low CR1 
expressing donors were incubated with primary anti-CR1 Ab and corresponding 
secondary Ab, washed, and added to the microfluidic device (Figure-6). The time 
required for RBCs to enter (Frame 3), pass through, and exit the 25 μm channels (Frame 
6), were measured and expressed as one value per RBC (Figure 6A). Quantifying this 
data (Figure 6B) showed that the number of CR1 molecules per RBC did correlate with 
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increasing membrane 
deformability.  High CR1 
expressing RBCs required about 
half the time (0.78±.18 s) to pass 
through the microchannels 
compared to low CR1 expressing 
RBCs (1.42±.22 s), and about a 
third the time required compared to 
control RBCs (2.21±.18 s). This, in 
addition to experiments using laser-
optical tweezers conducted by our 
collaborators at Harvard Medical 
School (Glodek et al., 2010) strongly suggests that CR1 ligation increases RBC 
membrane deformability directly, a process that likely would increase the efficacy of the 
immune-adherence transfer.  
 
CR1-Mediated ATP Release is Critical for the Interaction Between CR1 and 
Complement-Opsonized Particles 
Recently, extracellular ATP was shown to be essential for effective removal of 
apoptotic particles by professional phagocytic cells. Therefore, we next asked whether 
CR1 ligation would elicit an ATP release that would be relevant in the immune complex 
binding and transfer.  We showed that ligation of CR1 by complement opsonized beads 
produced a sustained and robust ATP release (Brodsky, data submitted for publication). 
Figure 6: Ligation of CR1 increases RBC membrane deformability. A) 
Sequential imaging (3 frames/s) of RBC folding upon entering 25 μm 
long microfluidic device, passing through and exiting, regaining its 
original shape. Every third frame is shown. B) Ligation of RBC CR1 
decreases the time required for RBC to pass through microchannels. 
The extent of the decrease in the time required for RBCs to pass 
through the microchannels depends directly on the number of CR1 
molecules on the surface of RBCs. Each dot represents one RBC. The 
results are representative of five independent experiments using 
different anti-CR1 Ab and different high or low CR1 donors. 
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We next asked whether the CR1 promoted ATP release plays an autocrine role in 
modulating membrane deformability as well as the binding efficacy of CR1 to 
complement-opsonized particles. To investigate this hypothesis, we incubated RBCs with 
complement-opsonized beads in the 
presence or absence of apyrase 
(ATP adenosine diphosphatase), a 
molecule that hydrolyzes 
extracellular ATP. Our results 
(Figure-7) show that the removal of 
extracellular ATP significantly 
decreases the binding efficiency 
from 22.1% positive complement-
opsonized beads to RBC to .34% 
binding, respectively (Figure 7A).  
In addition, our lab also showed that 
the effect of complement ligation to 
CR1 depends critically on casein 
kinase II (CKII) activity (Glodek et al., 2010). Therefore, in a separate experiment, RBCs 
were pre-incubated with specific CKII inhibitor TBB, and then incubated with 
complement-opsonized beads (Figure 7B). The results show that prevention of RBC 
ATP release by inhibition of RBC CKII activity decreased the percentage of beads bound 
to RBC from 31.1% to 17.4%. Importantly, the addition of 20 mM ATP back to the 
inhibited-RBC restored the binding efficacy to the initial levels (Figure 7B, right panel). 
Figure 7: Ligation of RBC CR1 is dependent on the presence of 
extracellular ATP. A) Hydrolysis of extracellular ATP by apyrase decreases 
the binding efficiency of complement-opsonized microbeads to RBC CR1. 
RBCs were pretreated with 5 U/mL apyrase before incubation with either 
control or complement-opsonized microbeads. Results were measured by 
flow cytometry. B) Inhibition of ATP release via CKII inhibition decreases 
binding efficiency of complement-opsonized microbeads to RBC CR1. RBCs 
were pretreated with 40 μM TBB before incubation with complement-
opsonized beads in the absence or presence of 20 nM ATP. Results were 
analyzed by flow cytometry. 
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Taken together, these results indicate that extracellular ATP is critical in mediating the 
binding efficiency of complement-opsonized particles to RBC CR1.  
 
Extracellular ATP is an Essential Component to CR1 Clustering 
The results in Figure 7 indicate that extracellular ATP is required in modulating 
the binding avidity of complement-opsonized particles to CR1 as RBCs circulate from 
the binding site to the liver and spleen. One possible explanation for these results is that 
ATP is essential for CR1 to cluster upon complement ligation. To test this, RBCs were 
incubated with Alexa Fluor 647-labeled complement-opsonized beads in the presence or 
absence of apyrase (Figure-8). The cells were then fixed in 0.5% acrolein, blocked, and 
incubated with CR1 using Alexa Fluor 488 directly labeled YZ1 anti-CR1 mAB. The 
fluorescent intensity profiles of CR1 in buffer and apyrase treated RBCs were analyzed 
through immunofluorescence 
microscopy against the intensity 
profile of complement-opsonized 
particles.  The results (Figure 8) 
show that in the presence of 
apyrase, CR1 (green) was scattered 
throughout the RBC, compared to 
the cells in buffer, which appear to 
cluster around the microbead (red). This suggests that apyrase, or the lack of extracellular 
ATP, prevented the clustering of CR1, therefore lowering the binding avidity of CR1 to 
complement particles. 
Figure 8: Extracellular ATP is critical in maintaining CR1 
clustering. A) Apyrase prevents clustering of CR1 bound 
complement-opsonized microbeads. RBC in the absence 
(upper row) or presence of 5 U/mL apyrase (lower row) were 
incubated with Alexa Fluor 647 complement-opsonized 
microbeads for 30 minutes, washed, and incubated with Alexa 
Fluor 488 labeled anti-CR1 Ab. 
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DISCUSSION 
 
 
 The most important function of RBCs, delivering oxygen to tissues and removing 
carbon dioxide, is largely dependent on the deformability of the membrane. The dynamic 
link between the cell membrane and the cytoskeleton underneath is essential for RBCs to 
deform efficiently and pass rapidly through narrow capillaries. The data presented in this 
project investigates a lesser known function of RBCs regarding complement binding, and 
identifies a novel functional consequence of RBC complement receptor-1 (CR1) 
engagement that is relevant to the process of immune adherence clearance. By binding 
and removing circulating immune complexes, RBCs help ensure a non-inflammatory 
environment, by preventing the direct interaction between circulating neutrophils and free 
proinflammatory immune complexes.  We and others have previously shown that CR1 
plays a key role in erythrocyte immune adherence clearance. We thus investigated the 
effect of CR1 ligation on RBC membrane deformability through microchannel networks. 
The data from this project show that ligation of CR1 significantly decreases RBCs 
passage time through the channels, which directly depends on the genetically inherited 
number of CR1 molecules present on RBC membranes. 
Previous studies have demonstrated that mechanical stimulation of RBCs 
increased membrane tension and augmented the permeability for Ca
++
 influx. Here, we 
showed that ligation of CR1 promotes a Ca
++
 influx, with an amplitude directly 
dependent on the expression levels of CR1 on RBC membranes. This project identified 
the presence of TRPC1 on human RBC membranes and its involvement in CR1 mediated 
Ca
++
 influx, by using a custom made inhibitory antibody against TRPC1. 
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We previously showed that CR1 is constitutively dispersed on the surface of 
circulating RBCs and clusters upon ligation with complement-opsonized particles due to 
its interactions with the scaffolding protein, FAP-1. Others have shown that this 
distinctive clustering on RBC helps prevent erythro-phagocytosis by inhibiting the zipper 
mechanism of phagocytosis, a process that requires a continuous, uniform deposition of 
complement fragments on the target cells (Swanson & Baer, 1995). In addition, ATP 
release by apoptotic cells was shown to be critical in recruiting macrophages and 
enhancing phagocytosis of apoptotic cells in vitro. We have shown that ligation of RBC 
CR1 promotes ATP release. This project continued this work by investigating the role of 
extracellular ATP following CR1 ligation. The loss of complement engagement with CR1 
following enzymatic removal of extracellular ATP implicated that ATP maintains a 
critical role in the process of regulating CR1 clustering and binding capabilities, both 
crucial processes are necessary for sustaining the shear stress encountered by circulating 
RBCs and avoiding erythro-phagocytosis by macrophages. 
In conclusion, this project demonstrated that ligation of RBC CR1 triggers a 
significant Ca
++
 influx, and activates a signaling pathway that depends on CKII and PKA 
activity, leading to a significant increase in plasma membrane deformability through 
phosphorylation of β-spectrin. Furthermore, our data showed that ligation and clustering 
of CR1 is critically dependent on the extracellular ATP released as part of this signaling 
cascade. Recognition of the signaling pathway triggered by CR1 ligation will allow for 
targeted modulation regarding the signaling events of immune adhesion, and the immune 
transfer process relevant in pathologies associated with complement deficiencies, such as 
sepsis, lupus, rheumatoid arthritis, etc.  Given the increased functional advantage 
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(increased membrane deformability, increased efficiency in binding, transporting, and 
transferring of complement-opsonized particles) of high CR1 expression levels, one can 
also speculate on the possibility that transfusion of stored blood from high RBC CR1 
donor to patients with excessive complement activation could be potentially 
advantageous in restoring a non-inflammatory environment. 
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